Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP6V1C2 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |
mRNA | RNF223 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.003 |
mRNA | ATAD2B | CTRPv2 | pan-cancer | AAC | 0.37 | 0.003 |
mRNA | WDR5 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | ZNF275 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |
mRNA | WDR43 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.003 |
mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | PHF20L1 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.003 |
mRNA | ALX4 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.003 |
mRNA | ZNF326 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |